Application 202260
- Type
- ANDA
- Sponsor
- AMNEAL PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NORETHINDRONE | NORETHINDRONE | TABLET;ORAL-28 | 0.35MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50090-3235 | Norlyda | norethindrone | A-S Medication Solutions | ANDA | Current |
| 50090-3235 | Norlyda | norethindrone | A-S Medication Solutions | ANDA | Current |
| 51660-127 | NORLYROC | norethindrone | Ohm Laboratories Inc. | ANDA | Current |
| 69238-1583 | Norlyda | norethindrone | Amneal Pharmaceuticals LLC | ANDA | Current |
| 69238-1583 | Norlyda | norethindrone | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1583 | Norlyda | norethindrone | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1583 | Norlyda | norethindrone | Amneal Pharmaceuticals NY LLC | ANDA | Current |